Medtronic PLC
MDT87.270USD
0.000
Market hours （ET）Quotes delayed by 15 min
111.87BMarket Cap
26.26P/E TTM
More Details of Medtronic PLC Company
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Company Info
Ticker SymbolMDT
Company nameMedtronic PLC
IPO dateNov 21, 1977
Founded at2014
CEOMr. Geoffrey S. (Geoff) Martha
Number of employees- -
Security typeOrdinary Share
Fiscal year-endNov 21
AddressBuilding Two Parkmore Business Park West
CityDUBLIN
Stock exchangeNYSE Consolidated
CountryIreland
Postal codeH91 4K49
Phone1135314381700
Websitehttps://www.medtronic.com/
Ticker SymbolMDT
IPO dateNov 21, 1977
Founded at2014
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.03M
+0.45%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President, President - Cardiovascular Portfolio
Executive Vice President, President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
486.64K
-0.61%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
111.10K
+90.72%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
47.95K
+4.05%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.16K
+4.88%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
39.00K
-1.45%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
30.75K
--
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.52K
+9.50%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.03M
+0.45%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President, President - Cardiovascular Portfolio
Executive Vice President, President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
486.64K
-0.61%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
111.10K
+90.72%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
47.95K
+4.05%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Surgical & Endoscopy
1.60B
19.25%
Cardiac Rhythm & Heart Failure
1.54B
18.63%
Cranial & Spinal Technologies
1.25B
15.07%
Structural Heart & Aortic
874.00M
10.54%
Specialty Therapies
732.00M
8.83%
Other
2.29B
27.68%
By RegionUSD
Name
Revenue
Proportion
United States
4.24B
51.10%
Rest of World
4.03B
48.56%
Ireland
28.00M
0.34%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Surgical & Endoscopy
1.60B
19.25%
Cardiac Rhythm & Heart Failure
1.54B
18.63%
Cranial & Spinal Technologies
1.25B
15.07%
Structural Heart & Aortic
874.00M
10.54%
Specialty Therapies
732.00M
8.83%
Other
2.29B
27.68%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.70%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Global Advisors (US)
4.68%
Capital Research Global Investors
3.24%
JP Morgan Asset Management
2.18%
Other
74.82%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.70%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Global Advisors (US)
4.68%
Capital Research Global Investors
3.24%
JP Morgan Asset Management
2.18%
Other
74.82%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
38.97%
Investment Advisor
36.14%
Research Firm
3.89%
Pension Fund
2.25%
Bank and Trust
2.04%
Hedge Fund
1.91%
Sovereign Wealth Fund
1.25%
Insurance Company
0.38%
Individual Investor
0.25%
Other
12.90%
Institutional Shareholding
Updated: Thu, Feb 20
Updated: Thu, Feb 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
3759
1.13B
87.77%
+9.53M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
2023Q1
3738
1.14B
85.40%
-14.71M
2022Q4
3689
1.13B
84.79%
-25.98M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
123.63M
9.64%
+776.44K
+0.63%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
68.04M
5.31%
+1.54M
+2.32%
Dec 31, 2024
State Street Global Advisors (US)
60.44M
4.71%
-293.90K
-0.48%
Dec 31, 2024
Capital Research Global Investors
33.20M
2.59%
+571.70K
+1.75%
Dec 31, 2024
JP Morgan Asset Management
24.34M
1.9%
+2.87M
+13.36%
Dec 31, 2024
Geode Capital Management, L.L.C.
27.06M
2.11%
+574.05K
+2.17%
Dec 31, 2024
MFS Investment Management
19.23M
1.5%
-3.64M
-15.91%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
14.57M
1.14%
-1.01M
-6.49%
Dec 31, 2024
DWS Investment GmbH
14.66M
1.14%
+197.49K
+1.37%
Dec 31, 2024
BlackRock Financial Management, Inc.
13.22M
1.03%
+764.34K
+6.14%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
Absolute Select Value ETF
5.64%
Polen Capital International Growth ETF
4.62%
Cullen Enhanced Equity Income ETF
4.3%
Madison Covered Call ETF
4.15%
iShares U.S. Medical Devices ETF
4.06%
JPMorgan Healthcare Leaders ETF
3.78%
USCF Dividend Income Fund
3.72%
Madison Dividend Value ETF
3.66%
iShares Large Cap Value Active ETF
3.34%
First Trust Active Global Quality Income ETF
3.26%
View more
Absolute Select Value ETF
Proportion5.64%
Polen Capital International Growth ETF
Proportion4.62%
Cullen Enhanced Equity Income ETF
Proportion4.3%
Madison Covered Call ETF
Proportion4.15%
iShares U.S. Medical Devices ETF
Proportion4.06%
JPMorgan Healthcare Leaders ETF
Proportion3.78%
USCF Dividend Income Fund
Proportion3.72%
Madison Dividend Value ETF
Proportion3.66%
iShares Large Cap Value Active ETF
Proportion3.34%
First Trust Active Global Quality Income ETF
Proportion3.26%
Dividend
A total of
16.68B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Mar 02, 2023
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023
Mar 24, 2023
Apr 14, 2023
Mar 23, 2023
Dec 08, 2022
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022
Dec 21, 2022
Jan 13, 2023
Dec 20, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
